Charles River provides medical-device manufacturers ISO 10993 biocompatibility testing spanning in vitro and in vivo assessments.
Competing Products
Charles River Laboratories
Global biomedical research support for drug development.
Founded
1947Global biomedical research support for drug development.
Founded in Wilmington, Massachusetts, Charles River Laboratories International, Inc. is a global non-clinical contract research organization dedicated to advancing drug discovery and development. The company offers a comprehensive range of services including drug discovery, non-clinical development, and safety testing. Operating through three main segments—Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions—Charles River provides essential support for the biomedical research community worldwide.
Notable figures associated with Charles River Laboratories include key scientists and industry experts who drive innovation within the company. The organization has attracted significant investment from leading healthcare and biotech investors. Key achievements include pioneering advancements in drug safety testing and expanding their global footprint to serve clients in the United States, Europe, Canada, and the Asia Pacific. Overall, Charles River Laboratories has had a profound impact on the biomedical research field, facilitating critical developments in drug discovery and safety assessment.
Companies similar to Charles River Laboratories include Alacrita, Beactica Therapeutics, WuXi Biologics and Jubilant Biosys.
Charles River Laboratories was founded in 1947.
Charles River Laboratories' headquarters is located in Wilmington, MA, US.
Charles River Laboratories' most recent funding round was for $1B (USD) in March 2021.
As of Mar 23, 2021, Charles River Laboratories has disclosed funding of $1.5B (USD). Undisclosed round amounts are excluded.
Charles River Laboratories has 20,000 employees as of Feb 6, 2024.
Jubilant Biosys
jubilantbiosys.com